African-Americans with Type 2 diabetes taking a Novo Nordisk drug showed improvements in blood sugar,...
The number of states with an obesity prevalence of 30% or more tripled in two...
WellDoc, a healthcare company that develops technology solutions to improve chronic disease management outcomes and...
Bayer Diabetes Care has successfully completed certification of its A1CNow+ and A1CNow Selfcheck devices under...
In high-risk adults with Type 2 diabetes, researchers have found that two therapies may slow...
PositiveID announced that development of its breath glucose-detection device prototype will be completed by year's...
Research and development pipelines are flowing with a record number of drugs for treating diabetes...
Women with Type 1 diabetes may not necessarily reduce their risk of heart disease if...
Diabetica Research Solutions announced that its diabetes energy formula now is available on CVS.com, in...
A leader of advanced diabetes management solutions is creating a free program that combines advanced...
The Juvenile Diabetes Research Foundation has given two research grants to drug maker Biodel to...
A week away at summer camp is a tradition for many kids in the United...
An enzyme produced by the body may make it easier to detect diabetes, according to...
LifeScan last week introduced the new OneTouch Delica lancing system, a lancing product designed to...
In an effort to curb chronic diseases, CVS/pharmacy and the 50 Million Pound Challenge are...
Nipro has named a new president for its Nipro Diagnostics division, the company announced Thursday....
Sanofi-Aventis and the Juvenile Diabetes Research Foundation announced they jointly will develop therapeutic treatments for...
An investigational treatment for Type 2 diabetes by Boehringer Ingelheim Pharmaceuticals significantly lowered blood sugar,...
A recently approved drug for Type 2 diabetes made by Novo Nordisk worked better than...
An inhaled insulin made by MannKind for patients with Type 2 diabetes provides glycemic control...
French drug maker Sanofi-Aventis has made a deal with U.S. drug maker Metabolex to license...
PatientPoint, whose core offering is a self-service kiosk that automates check-in and check-out processes in...
The Food and Drug Administration has granted orphan drug designation to an investigational treatment for...
An investigational drug used by Type 2 diabetes treatment-naive adult patients showed statistically significant reductions...
Diabetica Research Solutions on Tuesday announced the launch of DRSI ReStore! Energy, a diabetes-friendly energy...